Title : Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.

Pub. Date : 2020 Mar 30

PMID : 32235451






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Niraparib, Olaparib, and Rucaparib also demonstrated effective inhibitory potency in both advanced TNBC and ER-/HER2+ cells with and without BRCA-mutations. rucaparib estrogen receptor 1 Homo sapiens